Influence of <i>Mycobacterium</i> <i>bovis</i> Bacillus Calmette-Guerin on Antibody and Cytokine Responses to Human Neonatal Vaccination
Martin O. C. Ota(MRC Unit the Gambia), Arnaud Marchant(Université Libre de Bruxelles), Peter Aaby(Statens Serum Institut), Claire‐Anne Siegrist(University of Geneva), Johan Vekemans(MRC Unit the Gambia), Michael Kidd(MRC Unit the Gambia), Hilton Whittle(Centre for Human Genetics), Mariama Sanneh(MRC Unit the Gambia), Susanna E. Schlegel‐Haueter(University of Geneva), Keith P. W. J. McAdam(London School of Hygiene & Tropical Medicine), Melanie J. Newport(Addenbrooke's Hospital), Paul‐Henri Lambert(University of Geneva), Katherine Fielding
Cited by 290
Related Papers
Bulletin of the World Health Organization
|Bulletin of the World Health Organization|2001|7.2k
Interferon-γ –Receptor Deficiency in an Infant with Fatal Bacille Calmette–Guérin Infection
|New England Journal of Medicine|1996|878
Trained immunity, tolerance, priming and differentiation: distinct immunological processes
|Nature Immunology|2020|591
Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial
|The Lancet|2001|528
Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses
|Clinical Infectious Diseases|2017|453